A team of engineers at the University of Massachusetts Amherst has created a biohybrid mesh that harvests electrical power directly from human cells. The device integrates thin ribbons of piezoelectric material with living tissue to create a continuous, renewable power source for medical electronics.
This research, published in Science Advances, suggests a fundamental shift in how biomedical devices could be powered. Traditional implanted electronics rely on centralized batteries that are bulky, inflexible, and require surgical replacement when depleted. The new approach distributes energy harvesting across the device itself, mimicking how biological systems distribute power production throughout every cell.
How the technology works
The device uses lead zirconate titanate, or PZT, a material that converts mechanical energy into electrical energy. The researchers arranged thin PZT ribbons on an ultrathin, flexible polymer platform, then seeded the surface with human cardiac cells. As the cells grew, they meshed seamlessly with the electronic components, creating a biohybrid system that generates electricity from cellular movement and electrical activity.
The engineers explain that the human body functions as a distributed power network rather than a centralized one. Every cell produces its own energy - some as electrical impulses like nerve signals, some as mechanical force like muscle contractions. The biohybrid harvester taps into this distributed energy, capturing power that would otherwise go unused.
Laboratory tests show the mesh generates ten times more power density than systems relying on centralized batteries. Because the films are extremely thin, they can be stacked in multiple layers to increase power output without becoming invasive. The researchers emphasize that this is currently laboratory research and has not yet been tested in living organisms.
This development matters because it addresses a critical limitation in biomedical electronics: power supply. Pacemakers, cochlear implants, deep brain stimulators, and emerging wearable health monitors all require reliable electricity. Batteries constrain how small these devices can be, how long they last, and how comfortably they integrate with tissue. A self-powering, cell-level interface could enable smaller, longer-lasting, more biocompatible implants that the body does not recognize as foreign objects. The improved biocompatibility comes from operating at the cellular scale rather than introducing bulk materials that trigger immune responses.